checkAd

    DGAP-News  644  0 Kommentare HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to prior year Q1 period

    DGAP-News: HAEMATO AG / Key word(s): Quarter Results
    HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100%
    to EUR 3.47 million, compared to prior year Q1 period

    26.05.2016 / 09:18
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------

    Corporate News of HAEMATO AG:

    Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR
    3.47 million, compared to prior year Q1 period

    In the first quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved
    IFRS Group sales of EUR 69.94 million (prior year period: EUR 45.16
    million), an operating result (EBIT) of EUR 3.47 million (prior year
    period: EUR 1.67 million) and a net profit of EUR 2.59 million (prior year
    period: EUR 1.23 million).
    "In the first quarter of 2016 HAEMATO achieved high growth in sales and
    profit. We feel well prepared for achievements above prior year periods for
    the next quarters in 2016.
    Hyaluronic acid and other products for the Lifestyle-Beauty customer
    segment in the development process as own HAEMATO products", says Dr.
    Christian Pahl, Member of the Management Board of HAEMATO AG.

    About HAEMATO:

    HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the
    business activities lies on the growth markets of patent free and patent
    protected medicinal products. Focal points are therapies with cancer, HIV
    and other chronic diseases.

    HAEMATO AG is listed in the Entry Standard (Open Market) on the
    Frankfurt Stock Exchange. Key figures for the share of HAEMATO AG:
    Subscribed capital: EUR 20,778,898
    Listed shares: ordinary shares
    ISIN: DE000619070
    WKN: 619070
    Stock symbol: HAE




    Contact:
    HAEMATO AG, Investor Relations
    Telefon: +49 (0)30 897 30 86 70
    ir@haemato.de


    ---------------------------------------------------------------------------

    26.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a
    service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    ---------------------------------------------------------------------------

    466795 26.05.2016


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to prior year Q1 period DGAP-News: HAEMATO AG / Key word(s): Quarter Results HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to prior year Q1 period 26.05.2016 / 09:18 The issuer is solely responsible for the …